[
    {
        "text": "For over a century,",
        "start": 3.47,
        "duration": 1.01
    },
    {
        "text": "we’ve taken advantage of the fact that special\nimmune cells called B cells",
        "start": 4.48,
        "duration": 3.7
    },
    {
        "text": "produce these sticky Y-shaped proteins called\nantibodies after they face a threat.",
        "start": 8.18,
        "duration": 4.56
    },
    {
        "text": "Now, you might not think stickiness is that\nbig of a flex,",
        "start": 12.74,
        "duration": 3.22
    },
    {
        "text": "but /just/ by sticking to things, antibodies\ncan shut down germs and protect you from getting",
        "start": 15.96,
        "duration": 4.579
    },
    {
        "text": "sick.",
        "start": 20.539,
        "duration": 1.0
    },
    {
        "text": "And we can use their stickiness to spot pretty\nmuch anything we want!",
        "start": 21.539,
        "duration": 2.83
    },
    {
        "text": "A virus.",
        "start": 24.369,
        "duration": 1.0
    },
    {
        "text": "A protein.",
        "start": 25.369,
        "duration": 1.0
    },
    {
        "text": "A hormone.",
        "start": 26.369,
        "duration": 1.0
    },
    {
        "text": "/Whatever/.",
        "start": 27.369,
        "duration": 1.0
    },
    {
        "text": "That’s why mass-produced monoclonal antibodies\nhave become essential tools in benchtop science",
        "start": 28.369,
        "duration": 4.011
    },
    {
        "text": "and in diagnostic testing, in addition to\ntheir medical uses.",
        "start": 32.38,
        "duration": 3.37
    },
    {
        "text": "But all of this relies on having /great/ antibodies\nthat really stick to their targets, or antigens.",
        "start": 35.75,
        "duration": 6.02
    },
    {
        "text": "And /finding/ a great antibody isn’t necessarily\neasy.",
        "start": 41.77,
        "duration": 3.23
    },
    {
        "text": "Antibody discovery can happen one of several\nways.",
        "start": 45.0,
        "duration": 3.02
    },
    {
        "text": "One option harkens back to the old-school\nidea of treating people",
        "start": 48.02,
        "duration": 3.22
    },
    {
        "text": "with the antibodies of someone else who’s\nrecovered from an infection.",
        "start": 51.24,
        "duration": 4.05
    },
    {
        "text": "Except, you just want their /best/ antibody.",
        "start": 55.29,
        "duration": 2.42
    },
    {
        "text": "So, you find and clone the B cell that makes\nit!",
        "start": 57.71,
        "duration": 3.4
    },
    {
        "text": "There are some slight variations in the methods.",
        "start": 61.11,
        "duration": 1.87
    },
    {
        "text": "But, generally speaking, these single B cell\nantibody technologies involve pulling B cells",
        "start": 62.98,
        "duration": 5.24
    },
    {
        "text": "from the blood or bone marrow of someone who’s\nbeen infected with a pathogen.",
        "start": 68.22,
        "duration": 3.47
    },
    {
        "text": "Then, you sort through them to find the one\nthat sticks the best.",
        "start": 71.69,
        "duration": 3.49
    },
    {
        "text": "Scientists don’t talk about “stickiness”,\nthough —",
        "start": 75.18,
        "duration": 1.71
    },
    {
        "text": "they call the strength of the interaction\nbetween an antibody and its antigen its /affinity/.",
        "start": 76.89,
        "duration": 5.1
    },
    {
        "text": "Once a high-affinity B cell is isolated,",
        "start": 81.99,
        "duration": 2.78
    },
    {
        "text": "researchers can paste its antibody-making\ngenes into cells that replicate",
        "start": 84.77,
        "duration": 3.63
    },
    {
        "text": "really, really quickly.",
        "start": 88.4,
        "duration": 1.16
    },
    {
        "text": "This allows them to make tons and tons of\ncopies of that antibody!",
        "start": 89.56,
        "duration": 3.39
    },
    {
        "text": "And all that can all be done pretty quickly\nwith a limited amount of antigen,",
        "start": 92.95,
        "duration": 3.67
    },
    {
        "text": "which makes it a great technology to use when\nyou want antibodies for emerging infections—",
        "start": 96.62,
        "duration": 4.13
    },
    {
        "text": "like, say, COVID-19.",
        "start": 100.75,
        "duration": 1.27
    },
    {
        "text": "It’s also been used to develop drugs for\nother viruses, including SARS and H1N1.",
        "start": 102.02,
        "duration": 4.93
    },
    {
        "text": "But it’s not perfect.",
        "start": 106.95,
        "duration": 1.0
    },
    {
        "text": "One of the biggest downsides is that you’re\nrelying on a person making good antibodies,",
        "start": 107.95,
        "duration": 4.279
    },
    {
        "text": "which doesn’t always happen.",
        "start": 112.229,
        "duration": 1.311
    },
    {
        "text": "Plus, somebody has to get sick!",
        "start": 113.54,
        "duration": 1.63
    },
    {
        "text": "Which is why, even to this day,",
        "start": 115.17,
        "duration": 1.63
    },
    {
        "text": "a lot of monoclonal antibody drugs are actually\ndeveloped in /mice/.",
        "start": 116.8,
        "duration": 3.76
    },
    {
        "text": "Modern-day mouse methods for producing antibodies\nare surprisingly similar to what doctors did",
        "start": 120.56,
        "duration": 4.43
    },
    {
        "text": "a hundred years ago",
        "start": 124.99,
        "duration": 1.0
    },
    {
        "text": "to make the first antitoxins and antivenoms.",
        "start": 125.99,
        "duration": 2.43
    },
    {
        "text": "You inject a pathogen or toxin into a mouse\nand wait for it to produce antibodies; those",
        "start": 128.42,
        "duration": 4.86
    },
    {
        "text": "are what become your drug.",
        "start": 133.28,
        "duration": 1.28
    },
    {
        "text": "But there’s /one/ big difference: the mice\nused today are a bit more /human/.",
        "start": 134.56,
        "duration": 4.21
    },
    {
        "text": "You see, since the 1980s, we’ve been replacing\nmouse antibody genes with human ones.",
        "start": 138.77,
        "duration": 4.88
    },
    {
        "text": "So, thanks to a clever bit of genetic engineering,",
        "start": 143.65,
        "duration": 2.33
    },
    {
        "text": "when the /mouse’s/ B cells come into contact\nwith an antigen,",
        "start": 145.98,
        "duration": 3.42
    },
    {
        "text": "they pump out /human/ antibodies.",
        "start": 149.4,
        "duration": 1.91
    },
    {
        "text": "That lowers the potential for unintended side\neffects,",
        "start": 151.31,
        "duration": 2.61
    },
    {
        "text": "like developing allergies to the animal proteins.",
        "start": 153.92,
        "duration": 2.67
    },
    {
        "text": "And yet, no human needs to be infected.",
        "start": 156.59,
        "duration": 2.22
    },
    {
        "text": "But it’s not a perfect method.",
        "start": 158.81,
        "duration": 1.56
    },
    {
        "text": "It turns out that humanized mouse antibodies\ntend to have lower affinities than purely",
        "start": 160.37,
        "duration": 4.75
    },
    {
        "text": "human /or/ purely mouse antibodies.",
        "start": 165.12,
        "duration": 2.47
    },
    {
        "text": "Plus, even though the immune response creates\nhuman antibodies,",
        "start": 167.59,
        "duration": 2.96
    },
    {
        "text": "it’s still a mouse-sized response.",
        "start": 170.55,
        "duration": 2.389
    },
    {
        "text": "And mouse immune systems just don’t tend\nto react as robustly to things as ours do.",
        "start": 172.939,
        "duration": 4.38
    },
    {
        "text": "In an ideal world, what you’d want is a\nway to skip the whole infecting something",
        "start": 177.319,
        "duration": 3.801
    },
    {
        "text": "bit and just quickly screen /billions/ of\npotential antibodies to find the best ones.",
        "start": 181.12,
        "duration": 4.729
    },
    {
        "text": "…and that’s exactly what phage-display\ntechnology does!",
        "start": 185.849,
        "duration": 3.241
    },
    {
        "text": "It relies on viruses that infect bacteria\ncalled bacteriophages… hence the phage part.",
        "start": 189.09,
        "duration": 5.09
    },
    {
        "text": "The “display” bit refers to the fact that\nresearchers insert the gene",
        "start": 194.18,
        "duration": 3.389
    },
    {
        "text": "for the sticky ends of antibodies into the\ngenetic code for the phage’s outer coat.",
        "start": 197.569,
        "duration": 4.701
    },
    {
        "text": "That way, they’re built into the outside,\nor /displayed/ on the phage, where they can",
        "start": 202.27,
        "duration": 4.02
    },
    {
        "text": "stick to potential antigens.",
        "start": 206.29,
        "duration": 1.32
    },
    {
        "text": "And it turns out we already have /billions/\nof different antibody genes that scientists",
        "start": 207.61,
        "duration": 3.79
    },
    {
        "text": "can plug into this system.",
        "start": 211.4,
        "duration": 1.809
    },
    {
        "text": "Researchers have gone through and sequenced\n/tons/ of B cells from people to create these",
        "start": 213.209,
        "duration": 3.64
    },
    {
        "text": "giant libraries of potential antibodies.",
        "start": 216.849,
        "duration": 2.841
    },
    {
        "text": "And they continue to add more sequences all\nthe time!",
        "start": 219.69,
        "duration": 2.03
    },
    {
        "text": "So, the idea here is that you create these\nbillions of different viruses,",
        "start": 221.72,
        "duration": 3.629
    },
    {
        "text": "and then you add them all to dishes with the\nantigen of interest.",
        "start": 225.349,
        "duration": 3.001
    },
    {
        "text": "Then, you rinse.",
        "start": 228.35,
        "duration": 1.279
    },
    {
        "text": "The phages with high affinity will grab on\nand hold tight, so they’ll stay in the dish,",
        "start": 229.629,
        "duration": 4.671
    },
    {
        "text": "while any that didn’t stick will get washed\naway.",
        "start": 234.3,
        "duration": 2.39
    },
    {
        "text": "This process can then be repeated over and\nover again until you get the very best antibody.",
        "start": 236.69,
        "duration": 4.46
    },
    {
        "text": "Finally, you take the ones that did stick,\nand you give them bacteria to infect.",
        "start": 241.15,
        "duration": 4.949
    },
    {
        "text": "And like all viruses do, they /make copies\nof themselves/—",
        "start": 246.099,
        "duration": 2.97
    },
    {
        "text": "so you end up with enough genetic material\nto sequence!",
        "start": 249.069,
        "duration": 3.211
    },
    {
        "text": "Then, all you have to do is put the awesome\nantibody gene into some kind of cellular production",
        "start": 252.28,
        "duration": 4.5
    },
    {
        "text": "system, and you’ve got your super potent\ndrug.",
        "start": 256.78,
        "duration": 2.41
    },
    {
        "text": "With no animals harmed!",
        "start": 259.19,
        "duration": 1.729
    },
    {
        "text": "Which makes it much cheaper than other methods.",
        "start": 260.919,
        "duration": 2.191
    },
    {
        "text": "Plus, it’s quick and efficient.",
        "start": 263.11,
        "duration": 2.32
    },
    {
        "text": "Researchers can screen billions of antibodies\n/per week/",
        "start": 265.43,
        "duration": 2.78
    },
    {
        "text": "to find the absolute best ones.",
        "start": 268.21,
        "duration": 2.12
    },
    {
        "text": "All of this makes it especially useful for\nquickly finding highly specific antibodies—",
        "start": 270.33,
        "duration": 4.16
    },
    {
        "text": "for example, the kind you need to develop\na rapid at-home test for an emerging disease.",
        "start": 274.49,
        "duration": 4.66
    },
    {
        "text": "Now, no matter which of these three technologies\nis used to discover antibodies, the work usually",
        "start": 279.15,
        "duration": 5.22
    },
    {
        "text": "doesn’t stop there.",
        "start": 284.37,
        "duration": 1.0
    },
    {
        "text": "That’s because the affinities of naturally-occuring\na ntibodies are typically kind of weak—",
        "start": 285.37,
        "duration": 4.299
    },
    {
        "text": "even for ones we consider to be “good”.",
        "start": 289.669,
        "duration": 2.261
    },
    {
        "text": "Luckily, affinity can be improved.",
        "start": 291.93,
        "duration": 2.43
    },
    {
        "text": "Once a candidate antibody has been found,\nscientists make tweaks to its sequence.",
        "start": 294.36,
        "duration": 4.6
    },
    {
        "text": "These mutated antibodies go through the phage\ndisplay process to find the ones with the",
        "start": 298.96,
        "duration": 4.0
    },
    {
        "text": "highest affinity possible.",
        "start": 302.96,
        "duration": 1.41
    },
    {
        "text": "Then /those/ get tweaked further to try to\nincrease their affinity even more.",
        "start": 304.37,
        "duration": 4.06
    },
    {
        "text": "And it’s mutate, rinse, repeat until you\nhave the best possible one.",
        "start": 308.43,
        "duration": 3.35
    },
    {
        "text": "All of these technological developments have\ncontributed to the soaring popularity of monoclonal",
        "start": 311.78,
        "duration": 4.81
    },
    {
        "text": "antibody treatments.",
        "start": 316.59,
        "duration": 1.09
    },
    {
        "text": "In fact, in 2018, seven of the top ten best\nselling drugs were monoclonal antibodies!",
        "start": 317.68,
        "duration": 5.09
    },
    {
        "text": "We’re talking more than 122 /billion/ dollars\nin sales.",
        "start": 322.77,
        "duration": 3.44
    },
    {
        "text": "But science is always trying to make drugs\n/better/, and antibodies are no exception.",
        "start": 326.21,
        "duration": 4.14
    },
    {
        "text": "---outro, supercut----\nBut here’s Michael with more on that.",
        "start": 330.35,
        "duration": 1.0
    },
    {
        "text": "--outro, dose---\nIf you want to hear more about the incredible",
        "start": 331.35,
        "duration": 1.36
    },
    {
        "text": "/future/ of antibody technologies...",
        "start": 332.71,
        "duration": 2.07
    },
    {
        "text": "well, the bad news is, there wasn’t enough\ntime for that in /this/ episode.",
        "start": 334.78,
        "duration": 3.109
    },
    {
        "text": "But the /good/ news is we’ll talk all about\nit in /the next/ episode!",
        "start": 337.889,
        "duration": 3.231
    },
    {
        "text": "You see, this is part two of our three-part\nminiseries on antibodies.",
        "start": 341.12,
        "duration": 3.94
    },
    {
        "text": "The link to part 1 is in the description,\nand you can come back tomorrow for the stunning",
        "start": 345.06,
        "duration": 3.9
    },
    {
        "text": "conclusion!",
        "start": 348.96,
        "duration": 1.0
    },
    {
        "text": "[ outro ]",
        "start": 349.96,
        "duration": 0.001
    }
]